The BCL2 gene, while previously known for its extensive study in breast cancer, especially ER-positive breast cancer [52,53], and its subtype-specific prognostic role [54], exhibited a marked change in its staining pattern within HER2-positive breast cancer according to the IHC result. The gene discussed is BCL2; the disease is breast carcinoma.